flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 in Patients with Obesity-Related Heart Failure and Type 2 Diabetes Patients with type 2 #diabetes

Inhibition of the sodium-glucose co-transporter SGLT2 by canagliflozin ameliorates diet-induced obesity by increasing intra-adipose sympathetic innervation

In contrast, exogenous leptin, at the dose (10 g/kg ip) that raised plasma leptin to the level occurring postprandially, reduced markedly plasma levels of ghrelin and attenuated food intake and these effects were reversed by the administration of specific IgG anti-leptin antibodies (47)

They could include worrying that youre eating too much, shaming yourself for what you just ate, or constantly planning your next meal, perhaps even while eating your current one

The process is designed to feel professional and accessible without the need for in-person visits

It can make a difference in the lives of those who rely on plasma-derived therapies

You can respond with something like, Everything was delicious, Im just comfortably full now. Or, Im pacing myself, I might grab more later. You dont owe anyone an explanation that youre on a weight loss medication if youre not comfortable sharing that